Tunch Akmandor, Biomedical Scientist and Researcher in Histopathology and OncoPathology at University College London Hospitals NHS Foundation Trust, shared on LinkedIn:
”I’m delighted to share that two of our abstracts have been accepted for poster presentation at SITC 2026! Heading to Phoenix.
I look forward to presenting our latest research to the immuno-oncology community at the Society for Immunotherapy of Cancer (SITC) Annual Meeting in Phoenix this November.
As a European representative within a SITC Special Interest Group, I am also looking forward to meeting fellow SIG members, colleagues and collaborators and contributing to wider conversations around the future of cancer immunotherapy.
Further details about our research will be shared once the SITC embargo permits. Stay tuned!
Other articles featuring Tunch Akmandor on OncoDaily.